HK1199878A1 - 作為促性腺激素釋放激素受體拮抗劑的螺二氫吲哚衍生物 - Google Patents
作為促性腺激素釋放激素受體拮抗劑的螺二氫吲哚衍生物Info
- Publication number
- HK1199878A1 HK1199878A1 HK15100323.1A HK15100323A HK1199878A1 HK 1199878 A1 HK1199878 A1 HK 1199878A1 HK 15100323 A HK15100323 A HK 15100323A HK 1199878 A1 HK1199878 A1 HK 1199878A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- gonadotropin
- receptor antagonists
- hormone receptor
- releasing hormone
- spiroindoline derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Pregnancy & Childbirth (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12151291 | 2012-01-16 | ||
PCT/EP2013/050676 WO2013107743A1 (en) | 2012-01-16 | 2013-01-15 | Spiroindoline derivatives as gonadotropin- releasing hormone receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1199878A1 true HK1199878A1 (zh) | 2015-07-24 |
Family
ID=47559493
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15100323.1A HK1199878A1 (zh) | 2012-01-16 | 2015-01-13 | 作為促性腺激素釋放激素受體拮抗劑的螺二氫吲哚衍生物 |
Country Status (25)
Country | Link |
---|---|
US (1) | US20140357655A1 (zh) |
EP (1) | EP2804867A1 (zh) |
JP (1) | JP2015503607A (zh) |
KR (1) | KR20140112075A (zh) |
CN (1) | CN104169287A (zh) |
AP (1) | AP2014007738A0 (zh) |
AU (1) | AU2013211091A1 (zh) |
BR (1) | BR112014017483A8 (zh) |
CA (1) | CA2860986A1 (zh) |
CL (1) | CL2014001871A1 (zh) |
CO (1) | CO7010832A2 (zh) |
CR (1) | CR20140343A (zh) |
CU (1) | CU20140088A7 (zh) |
DO (1) | DOP2014000167A (zh) |
EA (1) | EA201491344A1 (zh) |
GT (1) | GT201400153A (zh) |
HK (1) | HK1199878A1 (zh) |
IL (1) | IL233485A0 (zh) |
MA (1) | MA35867B1 (zh) |
MX (1) | MX2014008630A (zh) |
PE (1) | PE20141699A1 (zh) |
PH (1) | PH12014501616A1 (zh) |
SG (1) | SG11201403749VA (zh) |
TN (1) | TN2014000306A1 (zh) |
WO (1) | WO2013107743A1 (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR095785A1 (es) * | 2013-04-09 | 2015-11-11 | Bayer Pharma AG | Derivados de espiroindolina y composiciones farmacéutica de los mismos |
WO2015007606A1 (en) * | 2013-07-15 | 2015-01-22 | Bayer Pharma Aktiengesellschaft | Spiroindoline derivatives and pharmaceutical compositions thereof |
EP2881391A1 (en) | 2013-12-05 | 2015-06-10 | Bayer Pharma Aktiengesellschaft | Spiroindoline carbocycle derivatives and pharmaceutical compositions thereof |
WO2015082374A1 (en) * | 2013-12-05 | 2015-06-11 | Bayer Pharma Aktiengesellschaft | Spiroindoline-thiopyran-imine-oxide derivatives as gonadotropin-releasing hormone receptor antagonists and pharmaceutical compositions thereof |
WO2015091315A1 (en) * | 2013-12-19 | 2015-06-25 | Bayer Pharma Aktiengesellschaft | Spiro[indolin-3,4'-piperidine] derivatives as gnrh receptor antagonists |
EP3339846B1 (en) * | 2016-12-22 | 2020-12-09 | Malvern Panalytical B.V. | Method of measuring properties of a thin film stack |
MA49256A (fr) | 2017-06-05 | 2021-05-26 | ObsEva SA | Schémas posologiques comprenant un antagoniste de l'hormone de libération des gonadotrophines pour le traitement de l'endométriose |
CN107840851A (zh) * | 2017-12-21 | 2018-03-27 | 扬州大学 | 吲哚螺吡咯嗪化合物及其合成方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5849780A (en) * | 1992-01-30 | 1998-12-15 | Sanofi | 1-benzenesulfonyl-1-1,3-dihydroindol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present |
TW200522944A (en) * | 2003-12-23 | 2005-07-16 | Lilly Co Eli | CB1 modulator compounds |
-
2013
- 2013-01-15 MX MX2014008630A patent/MX2014008630A/es unknown
- 2013-01-15 EP EP13700304.2A patent/EP2804867A1/en not_active Withdrawn
- 2013-01-15 CA CA2860986A patent/CA2860986A1/en not_active Abandoned
- 2013-01-15 WO PCT/EP2013/050676 patent/WO2013107743A1/en active Application Filing
- 2013-01-15 JP JP2014551648A patent/JP2015503607A/ja active Pending
- 2013-01-15 AP AP2014007738A patent/AP2014007738A0/xx unknown
- 2013-01-15 CN CN201380014647.3A patent/CN104169287A/zh active Pending
- 2013-01-15 EA EA201491344A patent/EA201491344A1/ru unknown
- 2013-01-15 SG SG11201403749VA patent/SG11201403749VA/en unknown
- 2013-01-15 BR BR112014017483A patent/BR112014017483A8/pt not_active Application Discontinuation
- 2013-01-15 AU AU2013211091A patent/AU2013211091A1/en not_active Abandoned
- 2013-01-15 KR KR1020147022494A patent/KR20140112075A/ko not_active Application Discontinuation
- 2013-01-15 PE PE2014001114A patent/PE20141699A1/es not_active Application Discontinuation
- 2013-01-15 US US14/371,312 patent/US20140357655A1/en not_active Abandoned
-
2014
- 2014-07-02 IL IL233485A patent/IL233485A0/en unknown
- 2014-07-11 PH PH12014501616A patent/PH12014501616A1/en unknown
- 2014-07-15 MA MA37214A patent/MA35867B1/fr unknown
- 2014-07-15 CL CL2014001871A patent/CL2014001871A1/es unknown
- 2014-07-15 TN TNP2014000306A patent/TN2014000306A1/fr unknown
- 2014-07-16 CR CR20140343A patent/CR20140343A/es unknown
- 2014-07-16 GT GT201400153A patent/GT201400153A/es unknown
- 2014-07-16 CO CO14154059A patent/CO7010832A2/es not_active Application Discontinuation
- 2014-07-16 DO DO2014000167A patent/DOP2014000167A/es unknown
- 2014-07-16 CU CU2014000088A patent/CU20140088A7/es unknown
-
2015
- 2015-01-13 HK HK15100323.1A patent/HK1199878A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
EP2804867A1 (en) | 2014-11-26 |
BR112014017483A8 (pt) | 2017-07-04 |
CU20140088A7 (es) | 2014-12-26 |
US20140357655A1 (en) | 2014-12-04 |
DOP2014000167A (es) | 2014-08-31 |
WO2013107743A1 (en) | 2013-07-25 |
CA2860986A1 (en) | 2013-07-25 |
GT201400153A (es) | 2015-05-22 |
AP2014007738A0 (en) | 2014-07-31 |
AU2013211091A1 (en) | 2014-08-07 |
CN104169287A (zh) | 2014-11-26 |
EA201491344A1 (ru) | 2015-04-30 |
MA35867B1 (fr) | 2014-12-01 |
PH12014501616A1 (en) | 2014-10-13 |
PE20141699A1 (es) | 2014-11-29 |
KR20140112075A (ko) | 2014-09-22 |
BR112014017483A2 (pt) | 2017-06-13 |
CL2014001871A1 (es) | 2014-11-03 |
TN2014000306A1 (en) | 2015-12-21 |
CO7010832A2 (es) | 2014-07-31 |
IL233485A0 (en) | 2014-08-31 |
SG11201403749VA (en) | 2014-07-30 |
MX2014008630A (es) | 2014-08-29 |
CR20140343A (es) | 2014-09-08 |
JP2015503607A (ja) | 2015-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1203191A1 (zh) | 受體拮抗劑 | |
HK1252279A1 (zh) | 5- ht3受體拮抗劑 | |
HK1199878A1 (zh) | 作為促性腺激素釋放激素受體拮抗劑的螺二氫吲哚衍生物 | |
HUE039607T2 (hu) | Progeszteron antagonisták | |
SI2833864T1 (sl) | Farmacevtske formulacije, ki obsegajo antagoniste CCR3 | |
EP2874621A4 (en) | Mineralocorticoid receptor antagonists | |
IL244356A0 (en) | Formulations for cgrp receptor antagonists | |
HK1216101A1 (zh) | 用作促性腺激素釋放激素受體拮抗劑的螺二氫吲哚衍生物 | |
EP2846800A4 (en) | HETEROCYCLIC CGRP RECEPTOR ANTAGONISTS | |
GB201213698D0 (en) | Receptor antagonists II | |
GB201213699D0 (en) | Receptor antagonists II |